Bicycle Therapeutics plc (BCYC) Tops Q4 EPS by 5c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q4 EPS of ($1.01), $0.05 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c